Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/ct2/show/NCT01676870
Registration number
NCT01676870
Ethics application status
Date submitted
29/08/2012
Date registered
31/08/2012
Date last updated
7/02/2020
Titles & IDs
Public title
Exercise in Prevention of Metabolic Syndrome
Query!
Scientific title
Exercise in Prevention of Metabolic Syndrome
Query!
Secondary ID [1]
0
0
2011/1230
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
EX-MET
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Metabolic Syndrome
0
0
Query!
Condition category
Condition code
Metabolic and Endocrine
0
0
0
0
Query!
Metabolic disorders
Query!
Other
0
0
0
0
Query!
Research that is not of generic health relevance and not applicable to specific health categories listed above
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Behaviour - 1x4 aerobic interval training
Behaviour - 4x4 aerobic interval training
Behaviour - traditional moderate training
Experimental: 1x4 aerobic interval training - 1x4min aerobic interval training (1-AIT), 3 times a week
Experimental: 4x4 aerobic interval training - 4x4min aerobic interval training (4-AIT), vigorously exercise according to today's guidelines, 3 times a week
Active Comparator: traditional moderate training - traditional moderate training (CME), moderate exercise at least 30 min, 5 days a week or more, according to today's guidelines
Behaviour: 1x4 aerobic interval training
endurance training as walking/running "uphill" 3 times/week for 16 weeks (2 supervised sessions (treadmill) and 1 at home each week) at 90% of Hfmax. Warm-up 10 min at 70% of maximal heart frequency (Hfmax), 5min cool-down.
Behaviour: 4x4 aerobic interval training
endurance training as walking/running "uphill" 3 times/week for 16 weeks (2 supervised sessions (treadmill) and 1 at home each week) at 90% of Hfmax. Warm-up 10 min at 70% of maximal heart frequency (Hfmax), 3 min active pause between each interval, 5min cool-down.
Behaviour: traditional moderate training
moderate intensity treadmill training (50-70% of HRmax) for a minimum of 30min, 5 times a week for 16 weeks (2 supervised sessions and 3 or more home).
Query!
Intervention code [1]
0
0
Behaviour
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
cardiovascular risk factors constituting metabolic syndrome
Query!
Assessment method [1]
0
0
Endothelial function and blood pressure, biopsies from the m. vastus lateralis, Protein and expression levels, oxidized LDL and adiponectin in blood plasma
Query!
Timepoint [1]
0
0
up to 3 years
Query!
Eligibility
Key inclusion criteria
- metabolic syndrome defined according to the IDF-criteria
Query!
Minimum age
30
Years
Query!
Query!
Maximum age
70
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
- unstable angina
- recent cardiac infarction (4weeks)
- uncompensated heart failure
- severe valvular illness
- pulmonary disease
- uncontrolled hypertension
- kidney failure
- orthopedic/neurological limitations
- cardiomyopathy
- planned operations during the research period
- reluctant to sign the consent form
- drug or alcohol abuse
- participants in a parallel study
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Open (masking not used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/01/2012
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
15/12/2019
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
408
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment hospital [1]
0
0
School of Human Movement Studies, University of Queensland - St Lucia
Query!
Recruitment postcode(s) [1]
0
0
- St Lucia
Query!
Recruitment outside Australia
Country [1]
0
0
Brazil
Query!
State/province [1]
0
0
São Paulo
Query!
Country [2]
0
0
Ecuador
Query!
State/province [2]
0
0
Guayaquil
Query!
Country [3]
0
0
Germany
Query!
State/province [3]
0
0
Munich
Query!
Country [4]
0
0
Norway
Query!
State/province [4]
0
0
Stavanger
Query!
Country [5]
0
0
Norway
Query!
State/province [5]
0
0
Trondheim
Query!
Funding & Sponsors
Primary sponsor type
Other
Query!
Name
Norwegian University of Science and Technology
Query!
Address
Query!
Country
Query!
Other collaborator category [1]
0
0
Other
Query!
Name [1]
0
0
Helse Stavanger HF
Query!
Address [1]
0
0
Query!
Country [1]
0
0
Query!
Other collaborator category [2]
0
0
Other
Query!
Name [2]
0
0
Technical University of Munich
Query!
Address [2]
0
0
Query!
Country [2]
0
0
Query!
Other collaborator category [3]
0
0
Other
Query!
Name [3]
0
0
The University of Queensland
Query!
Address [3]
0
0
Query!
Country [3]
0
0
Query!
Other collaborator category [4]
0
0
Other
Query!
Name [4]
0
0
KJ Fisiosport
Query!
Address [4]
0
0
Query!
Country [4]
0
0
Query!
Other collaborator category [5]
0
0
Other
Query!
Name [5]
0
0
University of Sao Paulo
Query!
Address [5]
0
0
Query!
Country [5]
0
0
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
The primary objective of the study is to compare in a real-world setting the efficacy of
traditional training (today's guideline, vigorously or moderate exercise) and amount of
aerobic interval training (1-AIT) in reduction of risk factors constituting metabolic
syndrome.
The secondary objective is to compare the efficacy of traditional moderate training (today's
guideline) and amount of aerobic interval training (1-AIT vs. 4-AIT) in improving aerobic
capacity, cardiovascular function, skeletal muscle contractile function, skeletal muscle
energy metabolism, left ventricle systolic and diastolic function at rest and right
ventricular function.
The investigators hypothesized that aerobic interval training would reverse features of the
metabolic syndrome more than traditional training.
Query!
Trial website
https://clinicaltrials.gov/ct2/show/NCT01676870
Query!
Trial related presentations / publications
Tjonna AE, Ramos JS, Pressler A, Halle M, Jungbluth K, Ermacora E, Salvesen O, Rodrigues J, Bueno CR Jr, Munk PS, Coombes J, Wisloff U. EX-MET study: exercise in prevention on of metabolic syndrome - a randomized multicenter trial: rational and design. BMC Public Health. 2018 Apr 2;18(1):437. doi: 10.1186/s12889-018-5343-7.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Ulrik Wisløff, PhD prof
Query!
Address
0
0
Norwegian University of Science and Technology
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
Summary Results
For IPD and results data, please see
https://clinicaltrials.gov/ct2/show/NCT01676870
Download to PDF